NEW YORK, Nov. 10, 2023 /PRNewswire/ — The neurodiagnostic and monitoring devices market in US size is expected to grow by USD 827.88 million from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 6.19% during the forecast period, according to Technavio Research. The market has segmented by Product (ICP Monitoring devices, EEG devices, EMG devices, and Others), End-user (Hospitals, Clinics, and Laboratories), and Application (Stroke, Migraine, Epilepsy, Parkinsons disease, and Ischemic stroke). This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read a Free PDF Sample Report
Technavio has announced its latest market research report titled Neurodiagnostic and Monitoring Devices Market in US 2024-2028
Company Profile:
Advanced Brain Monitoring Inc., Ambu AS, Bio Signal Group Corp., Cadwell Industries Inc., Compumedics Ltd., Delsys Inc., ELMIKO BIOSIGNALS sp. z o.o., General Electric Co., Jordan NeuroScience, Koninklijke Philips N.V., Lifelines Neuro Company LLC, Masimo Corp., Medtronic Plc, Motion Lab Systems Inc, Natus Medical Inc., neurocare group AG, Nihon Kohden Corp., NovaSignal Corp., RAUMEDIC AG, Viasonix Ltd
Advanced Brain Monitoring Inc.: The company offers neurodiagnostics and monitoring devices such as Stat X series mobile EEG systems and B Alert systems.
• To gain access to more vendor profiles available with Technavio, buy the report!
Neurodiagnostic And Monitoring Devices Market In US: Segmentation Analysis
The ICP monitoring devices segment will be significant during the forecast period. An increased incidence of traumatic brain injury, cases of BTI and brain tumors, a rise in product launches as well a strong market player presence fuel the segment growth. Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report
“Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021”- Technavio
Neurodiagnostic And Monitoring Devices Market In US: Driver & Trend:
Driver
Increasing incidences and prevalence of neurological conditions
Growing demand for EEG procedures
Increasing initiatives and support from governments and healthcare organizations
The increasing incidences and prevalence of neurological conditions drive the market growth during the forecast period. A comprehensive range of neurological disorders, including epilepsy, stroke, Parkinsons’ disease, and brain tumors pose a high risk of developing a disability. Furthermore, healthcare professionals use neurodiagnostic and monitoring devices such as EEG, EMG, MEG, and ICP to diagnose neurological diseases for further interventions to save the lives of the patients.
Trend
The paradigm shift toward a hybrid brain-computer interface is an emerging market trend. Identify key trends, drivers, and challenges in the market. Download a sample report to gain access to this information.
Related Reports:
The dermatology diagnostic devices market size is estimated to grow at a CAGR of 10.12% between 2022 and 2027. The dermatology diagnostic devices market size is forecast to increase by USD 9,108.83 million.
The global sleep apnea diagnostic and therapeutic devices market size is estimated to grow by USD 3,299.44 million at a CAGR of 8.75% between 2022 and 2027.
What are the key data covered in this neurodiagnostic and monitoring devices market in US report?
CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the neurodiagnostic and monitoring devices market in US between 2023 and 2028.
Precise estimation of the neurodiagnostic and monitoring devices market in US size and its contribution to the market in focus on the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the neurodiagnostic and monitoring devices market in US
A thorough analysis of the market’s competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of neurodiagnostic and monitoring devices market in US vendors.
ToC:
Executive Summary
Market Landscape
Market Sizing
Historic Market Sizes
Five Forces Analysis
Market Segmentation by Product
Market Segmentation by End-user
Market Segmentation by Application
Market Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio